Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1988 1
1990 1
1991 2
1997 1
1998 1
2000 1
2001 1
2002 2
2003 2
2004 2
2005 3
2006 3
2008 2
2009 3
2010 4
2011 3
2012 3
2013 7
2014 4
2015 8
2016 6
2017 6
2018 3
2019 1
2020 5
2021 5
2022 1
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Diffuse Glioma Heterogeneity and Its Therapeutic Implications.
Nicholson JG, Fine HA. Nicholson JG, et al. Cancer Discov. 2021 Mar;11(3):575-590. doi: 10.1158/2159-8290.CD-20-1474. Epub 2021 Feb 8. Cancer Discov. 2021. PMID: 33558264 Review.
Diffuse gliomas represent a heterogeneous group of universally lethal brain tumors characterized by minimally effective genotype-targeted therapies. Recent advances have revealed that a remarkable level of genetic, epigenetic, and environmental heterogeneity exists within …
Diffuse gliomas represent a heterogeneous group of universally lethal brain tumors characterized by minimally effective genotype-targ …
Tumor antigens in glioma.
Nejo T, Yamamichi A, Almeida ND, Goretsky YE, Okada H. Nejo T, et al. Semin Immunol. 2020 Feb;47:101385. doi: 10.1016/j.smim.2020.101385. Epub 2020 Feb 6. Semin Immunol. 2020. PMID: 32037183 Review.
Still, the paucity of effective antigen targets remains a significant obstacle in safely and effectively treating glioblastoma and other malignant gliomas with relatively low mutation loads. In this review, we highlight the current understanding of and development of immun …
Still, the paucity of effective antigen targets remains a significant obstacle in safely and effectively treating glioblastoma and other mal …
Advanced MR Techniques for Preoperative Glioma Characterization: Part 2.
Hangel G, Schmitz-Abecassis B, Sollmann N, Pinto J, Arzanforoosh F, Barkhof F, Booth T, Calvo-Imirizaldu M, Cassia G, Chmelik M, Clement P, Ercan E, Fernández-Seara MA, Furtner J, Fuster-Garcia E, Grech-Sollars M, Guven NT, Hatay GH, Karami G, Keil VC, Kim M, Koekkoek JAF, Kukran S, Mancini L, Nechifor RE, Özcan A, Ozturk-Isik E, Piskin S, Schmainda KM, Svensson SF, Tseng CH, Unnikrishnan S, Vos F, Warnert E, Zhao MY, Jancalek R, Nunes T, Hirschler L, Smits M, Petr J, Emblem KE. Hangel G, et al. J Magn Reson Imaging. 2023 Jun;57(6):1676-1695. doi: 10.1002/jmri.28663. Epub 2023 Mar 13. J Magn Reson Imaging. 2023. PMID: 36912262 Free PMC article. Review.
Preoperative clinical MRI protocols for gliomas, brain tumors with dismal outcomes due to their infiltrative properties, still rely on conventional structural MRI, which does not deliver information on tumor genotype and is limited in the delineation of diffuse gliomas …
Preoperative clinical MRI protocols for gliomas, brain tumors with dismal outcomes due to their infiltrative properties, still rely o …
Advanced MR Techniques for Preoperative Glioma Characterization: Part 1.
Hirschler L, Sollmann N, Schmitz-Abecassis B, Pinto J, Arzanforoosh F, Barkhof F, Booth T, Calvo-Imirizaldu M, Cassia G, Chmelik M, Clement P, Ercan E, Fernández-Seara MA, Furtner J, Fuster-Garcia E, Grech-Sollars M, Guven NT, Hatay GH, Karami G, Keil VC, Kim M, Koekkoek JAF, Kukran S, Mancini L, Nechifor RE, Özcan A, Ozturk-Isik E, Piskin S, Schmainda K, Svensson SF, Tseng CH, Unnikrishnan S, Vos F, Warnert E, Zhao MY, Jancalek R, Nunes T, Emblem KE, Smits M, Petr J, Hangel G. Hirschler L, et al. J Magn Reson Imaging. 2023 Jun;57(6):1655-1675. doi: 10.1002/jmri.28662. Epub 2023 Mar 3. J Magn Reson Imaging. 2023. PMID: 36866773 Free PMC article. Review.
The GliMR COST action wants to raise awareness about the state of the art of advanced MRI techniques in gliomas and their possible clinical translation or lack thereof. This review describes current methods, limits, and applications of advanced MRI for the preoperative ass …
The GliMR COST action wants to raise awareness about the state of the art of advanced MRI techniques in gliomas and their possible cl …
Epidemiological characteristics and genetic alterations in adult diffuse glioma in East Asian populations.
Mo Z, Xin J, Chai R, Woo PYM, Chan DTM, Wang J. Mo Z, et al. Cancer Biol Med. 2022 Nov 1;19(10):1440-59. doi: 10.20892/j.issn.2095-3941.2022.0418. Cancer Biol Med. 2022. PMID: 36350002 Free PMC article. Review.
Multiple genome-wide association studies of various cohorts have revealed single nucleotide polymorphisms associated with overall and subtype-specific glioma susceptibility. Notably, only 3 risk loci-5p15.33, 11q23.3, and 20q13.33-were shared between p …
Multiple genome-wide association studies of various cohorts have revealed single nucleotide polymorphisms associated with overall and subtyp …
Visualization of Diagnostic and Therapeutic Targets in Glioma With Molecular Imaging.
Li D, Patel CB, Xu G, Iagaru A, Zhu Z, Zhang L, Cheng Z. Li D, et al. Front Immunol. 2020 Oct 30;11:592389. doi: 10.3389/fimmu.2020.592389. eCollection 2020. Front Immunol. 2020. PMID: 33193439 Free PMC article. Review.
Gliomas, particularly high-grade gliomas including glioblastoma (GBM), represent the most common and malignant types of primary brain cancer in adults, and carry a poor prognosis. ...Expanded international collaborations would accelerate translational research in th …
Gliomas, particularly high-grade gliomas including glioblastoma (GBM), represent the most common and malignant types of primar …
Genetic advances in glioma: susceptibility genes and networks.
Liu Y, Shete S, Hosking F, Robertson L, Houlston R, Bondy M. Liu Y, et al. Curr Opin Genet Dev. 2010 Jun;20(3):239-44. doi: 10.1016/j.gde.2010.02.001. Epub 2010 Mar 6. Curr Opin Genet Dev. 2010. PMID: 20211558 Free PMC article. Review.
Recent advances in human genome studies have opened new avenues for the identification of susceptibility genes for many complex genetic disorders, especially in the field of rare cancers such as glioma. To date, eight glioma susceptibility loci have be …
Recent advances in human genome studies have opened new avenues for the identification of susceptibility genes for many complex genet …
Gene of the month: PIK3CA.
Lai K, Killingsworth MC, Lee CS. Lai K, et al. J Clin Pathol. 2015 Apr;68(4):253-7. doi: 10.1136/jclinpath-2015-202885. Epub 2015 Feb 16. J Clin Pathol. 2015. PMID: 25688137 Review.
PIK3CA encodes the p110alpha catalytic subunit of phosphatidylinositol 3-kinase (PI3K) which through its role in the PI3K/Akt pathway is important for the regulation of important cellular functions such as proliferation, metabolism and protein synthesis, angiogenesis and a …
PIK3CA encodes the p110alpha catalytic subunit of phosphatidylinositol 3-kinase (PI3K) which through its role in the PI3K/Akt pathway …
The footprint of kynurenine pathway in every cancer: a new target for chemotherapy.
Ala M. Ala M. Eur J Pharmacol. 2021 Apr 5;896:173921. doi: 10.1016/j.ejphar.2021.173921. Epub 2021 Jan 30. Eur J Pharmacol. 2021. PMID: 33529725 Review.
Overactivation of kynurenine pathway in cancers provides an immunologically susceptible microenvironment for mutant cells to survive and invade surrounding tissues. ...Overactivation of kynurenine pathway, particularly overactivation of indoleamine 2,3-dioxygenase ( …
Overactivation of kynurenine pathway in cancers provides an immunologically susceptible microenvironment for mutant cells to survive …
IDH1 mutation is associated with a higher preoperative seizure incidence in low-grade glioma: A systematic review and meta-analysis.
Li Y, Shan X, Wu Z, Wang Y, Ling M, Fan X. Li Y, et al. Seizure. 2018 Feb;55:76-82. doi: 10.1016/j.seizure.2018.01.011. Epub 2018 Jan 31. Seizure. 2018. PMID: 29414139 Free article. Review.
PURPOSE: Gliomas, particularly low-grade gliomas (LGGs), are highly epileptogenic. ...Accordingly, there is a need for a better understanding of the mechanisms and risk factors of glioma-related epilepsy. The current study aimed to perform a comprehensive met …
PURPOSE: Gliomas, particularly low-grade gliomas (LGGs), are highly epileptogenic. ...Accordingly, there is a need for a bette …
81 results